These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29607922)

  • 1. A Standard Intervention Practice to Promote Appropriate Lamotrigine Therapy by Pharmacists.
    Shimamura H; Yamada H; Okada N; Uchikura T; Tanaka K; Sasaki T; Itabe H
    Biol Pharm Bull; 2018; 41(4):465-469. PubMed ID: 29607922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
    Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP
    J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy.
    Makus KG; McCormick J
    Clin Ther; 2007 Feb; 29(2):334-41. PubMed ID: 17472825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine-associated rash: to rechallenge or not to rechallenge?
    Lorberg B; Youssef NA; Bhagwagar Z
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):257-65. PubMed ID: 18845017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash.
    Ketter TA; Wang PW; Chandler RA; Alarcon AM; Becker OV; Nowakowska C; O'Keeffe CM; Schumacher MR
    J Clin Psychiatry; 2005 May; 66(5):642-5. PubMed ID: 15889953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful re-introduction of lamotrigine after initial rash.
    Besag FM; Ng GY; Pool F
    Seizure; 2000 Jun; 9(4):282-6. PubMed ID: 10880290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacists' opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action.
    Dhanani TC; Mantovani EH; Turner JR
    Int J Pharm Pract; 2017 Apr; 25(2):176-179. PubMed ID: 27677250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment of a cohort of lamotrigine users through community pharmacists: differences between patients who gave informed consent and those who did not.
    Knoester PD; Belitser SV; Deckers CL; Keyser A; Renier WO; Egberts AC; Hekster YA
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):107-12. PubMed ID: 15386696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of lamotrigine for adults with bipolar disorder in a private practice setting.
    Ginsberg LD
    CNS Spectr; 2006 May; 11(5):376-82. PubMed ID: 16641842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine treatment of adolescents with unipolar and bipolar depression: a retrospective chart review.
    Shon SH; Joo Y; Lee JS; Kim HW
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):285-7. PubMed ID: 24813210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder.
    Chang CC; Shiah IS; Yeh CB; Wang TS; Chang HA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):741-4. PubMed ID: 16442685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in prescription patterns to patients with bipolar syndromes. Increased use of lamotrigine and decreased use of lithium].
    Karanti A; Kardell M; Lundberg U; Landén M
    Lakartidningen; 2014 Dec; 111(51-52):2284-6. PubMed ID: 25514669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion of the new antiepileptic drug lamotrigine in Dutch clinical practice.
    Knoester PD; Belitser SV; Deckers CL; Keyser A; Renier WO; Egberts AC; Hekster YA
    Eur J Clin Pharmacol; 2004 Dec; 60(10):751-8. PubMed ID: 15619137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trial.
    Woo YS; Bahk WM; Jon DI; Joo YH; Kim W; Seo JS; Ahn YM; Chung SK; Won SH; Shin YC; Yoon BH; Jung SH; Seok JH; Lee YS; Kim Y; Min KJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1147-52. PubMed ID: 19540298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of lamotrigine and other antiepileptic drugs in paediatric patients at a Malaysian hospital.
    Ab Rahman AF; Ibrahim MI; Ismail HI; Seng TB
    Pharm World Sci; 2005 Oct; 27(5):403-6. PubMed ID: 16341748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rechallenge with lamotrigine after initial rash.
    Tavernor SJ; Wong IC; Newton R; Brown SW
    Seizure; 1995 Mar; 4(1):67-71. PubMed ID: 7788112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.